| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/11/2003 | US20030172411 Disease resistance factors |
| 09/11/2003 | US20030172409 Methods for increasing biomass of transgenic maize |
| 09/11/2003 | US20030172408 Transcription factor stress-related polypeptides and methods of use in plants |
| 09/11/2003 | US20030172407 Method of producing single chain protein in plant cells |
| 09/11/2003 | US20030172406 Methods for increasing Biomass of transgenic maize |
| 09/11/2003 | US20030172405 Comprises DNA encoding enzymatic polypeptide associated with dwarfed plant phenotypes and gibberellin biosynthesis; plant growth regulators |
| 09/11/2003 | US20030172404 Method of modifying plant characters by the targeted expression of a cell cycle control protein |
| 09/11/2003 | US20030172403 Transgenic rice, corn, barley or wheat which express heterologous nucleotide sequences coding proteins and plant regulatory polypeptides such as opaque 2 (O2), prolamin box factor (PBF) and rice endosperm bZIP proteins (REP) in seeds |
| 09/11/2003 | US20030172402 Transgenic trees exhibiting increased growth, biomass production and xylem fibre length, and methods for their production |
| 09/11/2003 | US20030172400 Comprises nucleotide sequences coding anthocyanidin-rutinoside acyltransferase (AR-AT) for improving/increaseing flower varieties; horticulture |
| 09/11/2003 | US20030172399 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 09/11/2003 | US20030172398 Novel delta-12 desaturase and methods of using it for synthesis of polyunsaturated fatty acids |
| 09/11/2003 | US20030172397 Papaya ringspot virus genes |
| 09/11/2003 | US20030172396 A nucleic acid encoding a transferase enzyme, resistance to a disease caused by Pseudoperonospora or Peronospora; genetic engineering |
| 09/11/2003 | US20030172395 Genetic engineering of plants through manipulation of lignin biosynthesis |
| 09/11/2003 | US20030172394 Selection and cloning methods |
| 09/11/2003 | US20030172393 Comprising a modified glucocorticoid receptor, for useing in testing, drug screening, finding drugs treating septic shock, asthma, inflammatory diseases, respiratory system disorders, autoimmune diseases |
| 09/11/2003 | US20030172392 Methods for injecting avian eggs |
| 09/11/2003 | US20030172391 A transgenic mouse; the enzyme for treating inflammation, smooth muscle contraction; animal models |
| 09/11/2003 | US20030172390 Mo54 gene disruptions, compositions and methods related thereto |
| 09/11/2003 | US20030172389 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema |
| 09/11/2003 | US20030172387 Tissue specific expression of exogenous proteins in transgenic chickens |
| 09/11/2003 | US20030171902 Sequence data combining method, sequence data combining apparatus and sequence data combining program |
| 09/11/2003 | US20030171878 Methods for the identification of genetic features for complex genetics classifiers |
| 09/11/2003 | US20030171570 Acetal phosphoramidites for linking with a nucleotide sequence, converting the acetal group to aldehyde, for conjugating biomolecules; acetalization, oxidation |
| 09/11/2003 | US20030171569 A genetic engineered DNA molecule, probes, vectors, gene expression is inhibited by a growth hormone, for treating tumor; antitumor agents |
| 09/11/2003 | US20030171568 Diagnosing tumor or cancer in a mammal, and inflammatory diseases or disorders; inflammatory bowel disease, colon cancer; immunoassay, immunotherapy |
| 09/11/2003 | US20030171567 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments |
| 09/11/2003 | US20030171566 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering |
| 09/11/2003 | US20030171564 Novel argS |
| 09/11/2003 | US20030171562 Amino acid derivative antibiotics dorrigocin, and lactimidomycin, culturing Streptomyces amphibiosporus; computer readable medium with stored nucleotide sequences information, computers for data processing |
| 09/11/2003 | US20030171559 A colony-stimulating factor hybrid molecules, computer analyzing the three dimensional structure protein, crystallization of the protein |
| 09/11/2003 | US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening |
| 09/11/2003 | US20030171552 A single-chain T-cell receptor covalently linked to single-chain antibody; anticarcinogenic agents for treating cancer |
| 09/11/2003 | US20030171551 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response |
| 09/11/2003 | US20030171548 Immunoreactive proteins where the percentage of immuno-reactive molecules as determined in a modified Lindmo-test is >81%; fermentation of culture of fluidized reactor; diagnosis of inflammatory and bone marrow displacing process |
| 09/11/2003 | US20030171547 Adipocyte-specific protein homologs |
| 09/11/2003 | US20030171546 Chimeric immunoreceptor useful in treating human cancers |
| 09/11/2003 | US20030171544 A novel alcohol dehydrogenase (ADHF1) from Pseudomonas fluorescens (DSM 50106) and to functional variants and to a process for enantiomorphic reduction of ketones to the corresponding alcohols by using such alcohol dehydrogenases |
| 09/11/2003 | US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides |
| 09/11/2003 | US20030171537 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| 09/11/2003 | US20030171443 Purification, isolation nucleic acids |
| 09/11/2003 | US20030171435 New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them |
| 09/11/2003 | US20030171336 A packaging cell line capable of complementing recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35. The cell line is preferably derived from primary, diploid human cells transformed by adenovirus E1 |
| 09/11/2003 | US20030171335 Antisense antiviral agent and method for treating ssRNA viral infection |
| 09/11/2003 | US20030171328 Non-invasive method for detecting target-RNA |
| 09/11/2003 | US20030171325 Apparatuses for solid-phase oligonucleotide synthesis and forming long polynucleotides. One exemplary method includes synthesizing a sense oligonucleotide; synthesizing an antisense oligonucleotide; annealing the sense and antisense |
| 09/11/2003 | US20030171324 Reagents which bind to human DESC1-like serine protease gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cancer, chronic obstructive pulmonary disease (COPD), |
| 09/11/2003 | US20030171322 Counterions of polycations used to compact nucleic acids profoundly affect shape and stability of particles formed. Shape is associated with differential serum nuclease resistance and colloidal stability. A surrogate for |
| 09/11/2003 | US20030171321 Immunostimulatory oligodeoxynucleotides |
| 09/11/2003 | US20030171318 Methods for inhibiting virus propagation and treating virus infection are provided which include administering to cells infected with viruses a compound capable of inhibiting viral budding from the cells. |
| 09/11/2003 | US20030171317 Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents |
| 09/11/2003 | US20030171314 Early protection of susceptible animals against foot and mouth disease (FMD) may be achieved by inoculating the animals with a vaccine comprising an interferon DNA sequence. One day after inoculation, animals have been found protected from |
| 09/11/2003 | US20030171313 Antisense oligonucleotides are provided which are complementary to and hybridizable with at least a portion of HCV RNA and which are capable of inhibiting the function of the HCV RNA. These oligonucleotides can be administered to |
| 09/11/2003 | US20030171311 Compounds, including enzymatic nucleic acid molecules, ribozymes, DNAzymes, nuclease activating compounds and chimeras such as 2',5'-adenylates, that modulate the expression and/or replication of hepatitis C virus |
| 09/11/2003 | US20030171310 Modulating the expression of RECQL. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding RECQL. Methods of using these compounds for modulation of RECQL expression and for |
| 09/11/2003 | US20030171291 Novel treatment |
| 09/11/2003 | US20030171289 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 09/11/2003 | US20030171283 Inhibin compositions and methods of enhancing production performance |
| 09/11/2003 | US20030171280 Compositions and methods for modulation of immune responses |
| 09/11/2003 | US20030171278 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 09/11/2003 | US20030171274 Antimicrobial proteins |
| 09/11/2003 | US20030171273 DNA of SEQ ID NO:1 is provided that encodes the transcription factor BP1, which is believed to be a repressor of the beta -globin gene. A host cell that is transformed with a vector that contains the DNA may be used to produce BP1. |
| 09/11/2003 | US20030171269 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 09/11/2003 | US20030171268 polynucleotides which identify and encode HuLEAP. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HuLEAP and a method for producing HuLEAP. |
| 09/11/2003 | US20030171267 Albumin fusion proteins |
| 09/11/2003 | US20030171266 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 09/11/2003 | US20030171254 Purified outer membrane protein of a Moraxella strain, particularly M. catarrhalis, having a molecular mass of about 200 kDa, is provided. The about 200 kDa outer membrane protein as well as nucleic acid molecules encoding the same are useful |
| 09/11/2003 | US20030171236 Alpha-amylase mutants |
| 09/11/2003 | US20030170914 Replicable probe array |
| 09/11/2003 | US20030170900 Deactivating and deleting a characteristic gene defining a detectable host characteristic and inserting a DNA fragment of interest into the modified host together with intact characteristic gene enabling confirmation of integration |
| 09/11/2003 | US20030170899 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
| 09/11/2003 | US20030170898 Method for intracellular modifications within living cells using pulsed electric fields |
| 09/11/2003 | US20030170897 Virus vector for transferring gene into renal cells |
| 09/11/2003 | US20030170896 Adeno-asociated virus (AAV) vectors that are capable of being transferred between cells; used to support comercially significant levels or rAAV particles without infectious helper virus or other harmful by-products |
| 09/11/2003 | US20030170895 Methods of making hypermutable cells using PMSR homologs |
| 09/11/2003 | US20030170894 Tryptophan containing low molecular weight polylysine, for use in receptor-mediated and nonreceptor-mediated gene delivery, both in vivo and in vitro |
| 09/11/2003 | US20030170891 RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| 09/11/2003 | US20030170890 Produced by conversion of healthy myocardial cell by stimulation with hormones, hormone analogs and/or cytokines; used for detecting and identifying substances acting on the heart |
| 09/11/2003 | US20030170888 Chimeric bird from embryonic stem cells |
| 09/11/2003 | US20030170885 Used for the transfer and expression of exogenous nucleotide sequences in a host cell or organism; gene therapy |
| 09/11/2003 | US20030170883 Wells formed within a frame made of a thermally conductive material which enables the wells to have relatively rigid walls which in turn makes it easier to handle |
| 09/11/2003 | US20030170879 Microbes and methods for remediation |
| 09/11/2003 | US20030170877 Using gene from Ralstonia eutropha strain TB64; bioremediation |
| 09/11/2003 | US20030170876 Methods for producing a polypeptide in a bacillus cell |
| 09/11/2003 | US20030170875 Genetic mutation underlying orthostatic intolerance and diagnostic and therapeutic methods relating thereto |
| 09/11/2003 | US20030170871 Alphavirus-based vectors for persistent infection |
| 09/11/2003 | US20030170869 D-aminoacylases, method for producing the same, and method for producing D-amino acids using the same |
| 09/11/2003 | US20030170866 Novel cyclin-selective ubiquitin carrier polypeptides |
| 09/11/2003 | US20030170865 Novel polypeptide of protein p140 and DNAs encoding it |
| 09/11/2003 | US20030170864 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/11/2003 | US20030170863 Prevents side effects such as systemic activation of coagulation system, bleeding |
| 09/11/2003 | US20030170860 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
| 09/11/2003 | US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 09/11/2003 | US20030170854 Recombinant human creatine kinase heterodimer with solution-stability |
| 09/11/2003 | US20030170849 Tyrosylprotein sulfotransferases |
| 09/11/2003 | US20030170847 Genes involved in isoprenoid compound production |
| 09/11/2003 | US20030170846 Having decreased immunogenicity relative to wild-types; lympocyte epitopes; serine proteases |
| 09/11/2003 | US20030170845 Tetrahydrofolate metabolic enzymes |
| 09/11/2003 | US20030170842 Crystal proteins comprising proline substitutions; vapor diffusion; nuclear magnetic resonance; high resolution |